MedPath
NMPA Approval

Naphazoline Hydrochloride Nasal Drops

国药准字H20198006

April 9, 2024

国药准字H33020460

Drug Information

盐酸萘甲唑啉滴鼻液

恒健

滴鼻剂

0.1%

化学药品

April 9, 2024

Company Information

Applicant Company

广东省江门市龙溪路117号

Manufacturing Company

广东省江门市龙溪路117号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸萘甲唑啉滴鼻液 - NMPA 批准文号 | MedPath